- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: R/R DLBCL
Total 601 results
-
Antengene CorporationActive, not recruitingRelapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)China
-
Sarit AssoulineNovartis; Hoffmann-La Roche; Quebec Clinical Research Organization in CancerCompletedDiffuse Large B Cell LymphomaCanada
-
The Lymphoma Academic Research OrganisationEpizyme, Inc.Active, not recruitingLymphoma | Follicular Lymphoma | DLBCLFrance, Belgium
-
Antengene CorporationTerminatedRelapsed/Refractory Diffuse Large B-cell LymphomaChina
-
The Lymphoma Academic Research OrganisationCompletedFollicular Lymphoma Patients (Phase IB) | Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II)France, Belgium
-
MorphoSys AGCompletedDiffuse Large B-cell LymphomaBelgium, Germany, United States, Austria, Czechia, France, Italy, Portugal, Spain
-
Herlev HospitalCompletedLymphoma, Large B-Cell, DiffuseDenmark
-
Hoffmann-La RocheTerminated
-
HutchmedWithdrawnFollicular Lymphoma | Waldenstrom Macroglobulinemia | Lymphoplasmacytic Lymphoma | NHL | DLBCL | Richter Syndrome | CLL/SLL | MCL | MZLUnited States, Spain, Australia, Israel, Italy, Poland, France
-
Icahn School of Medicine at Mount SinaiBristol-Myers SquibbCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Calithera Biosciences, IncTerminatedDiffuse Large B-cell LymphomaSpain, United States, Italy, Canada, France, United Kingdom
-
Calithera Biosciences, IncCompletedAdvanced Solid Tumor and Lymphoma MalignanciesUnited States, Spain, Italy, United Kingdom
-
Austin HealthMerck KGaA, Darmstadt, GermanyActive, not recruitingLymphomas Non-Hodgkin's B-CellAustralia
-
Novartis PharmaceuticalsTerminatedDiffuse Large B-cell LymphomaUnited States
-
Karyopharm Therapeutics IncSuspendedRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Nervous System Lymphoma | Recurrent Primary Vitreoretinal DLBCL | Refractory Nervous System Lymphoma | Refractory Primary Vitreoretinal DLBCLUnited States
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B-cells Non-Hodgkin LymphomaItaly
-
AbbVieCompletedCancer | Advanced Solid Tumors | Hematologic MalignanciesUnited States, Japan, Netherlands, Spain
-
Ruijin HospitalActive, not recruiting
-
M.D. Anderson Cancer CenterGenentech, Inc.; CelgeneCompleted
-
Rush University Medical CenterTerminatedDiffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Transformed Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Refractory Anaplastic Large Cell Lymphoma | Refractory Transformed Non-Hodgkin Lymphoma | Recurrent...United States
-
Merck Sharp & Dohme LLCTerminatedDLBCL | AML Including AML de Novo and AML Secondary to MDS
-
MorphoSys AGCompletedDiffuse Large B Cell LymphomaFrance, Italy, United States, Spain
-
University Hospital Southampton NHS Foundation...Hoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited Kingdom
-
Molecular Templates, Inc.TerminatedLeukemia, Lymphocytic, Chronic, B-Cell | Diffuse Large B Cell Lymphoma | Blood Cancer | Hematological Malignancy | Small Lymphocytic Leukemia | Non-Hodgkin's B-cell LymphomaUnited States, Canada, Georgia, Belarus, Spain, Israel, Moldova, Republic of, Poland, Serbia, Ukraine
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell LymphomaAustria, Canada, United States
-
Acerta Pharma BVAstraZenecaCompletedDiffuse Large B Cell Lymphoma | NHL | Non-hodgkin's Lymphoma | DLBCLUnited States, United Kingdom
-
The Catholic University of KoreaActive, not recruitingLymphoma, Large B-Cell, DiffuseKorea, Republic of
-
Fondazione Italiana Linfomi ONLUSActive, not recruitingRelapsed T-Cell Lymphoma | Refractory T-Cell LymphomaItaly
-
MorphoSys AGICON Clinical ResearchActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Hungary, Italy, Poland, Spain, Czechia, Germany, Australia, Austria, Canada, Croatia, Finland, France, Israel, Korea, Republic of, New Zealand, Portugal, Romania, Serbia, Singapore, Taiwan, Turkey, United Kingdom
-
Denovo Biopharma LLCCompletedDiffuse Large B-Cell LymphomaUnited States, China
-
Opna-IO LLCCompletedFollicular Lymphoma | Small Cell Lung Cancer | Solid Tumor | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Ovarian Clear Cell Carcinoma | Uveal Melanoma | Advanced MalignanciesUnited States
-
TG Therapeutics, Inc.TerminatedFollicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic LymphomaUnited States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
-
Novartis PharmaceuticalsCompletedDiffuse Large B-cell Lymphoma (DLBCL)United States
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia (ALL) | Diffuse Large B-Cell Lymphoma (DLBCL)United States
-
Incyte CorporationCompletedB-cell LymphomaUnited States, Spain, Italy
-
C. Babis AndreadisGlaxoSmithKline; University of California, San FranciscoCompletedDiffuse Large Cell Lymphoma Relapsed/RefractoryUnited States
-
Fondazione Italiana Linfomi ONLUSJanssen Pharmaceutica; Janssen-Cilag Ltd.; Centro di Riferimento per l'Epidemiologia...CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-cell Lymphoma RefractoryItaly
-
Fondazione Italiana Linfomi ONLUSTerminatedDiffuse, Large B-Cell, LymphomaItaly
-
Novartis PharmaceuticalsCompletedSoft Tissue Sarcoma | Small Cell Lung Cancer | Gastric Adenocarcinoma | Diffuse Large B Cell Lymphoma | Esophageal Adenocarcinoma | Ovarian Adenocarcinoma | Castration Resistant Prostate Adenocarcinoma | Advanced Well-differentiated Neuroendocrine TumorsUnited States
-
GlaxoSmithKlineTerminatedNeoplasmsUnited States, Spain, Canada, Australia
-
Shanghai Henlius BiotechCompleted
-
University of Colorado, DenverNational Cancer Institute (NCI)WithdrawnDiffuse Large B Cell Lymphoma
-
Incyte CorporationTerminatedSolid TumorsUnited States, Belgium, France
-
Curis, Inc.CompletedRelapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc AlterationsUnited States, Spain
-
Ruijin HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
Weill Medical College of Cornell UniversityFDA Office of Orphan Products Development; The Leukemia and Lymphoma Society; Karyopharm Therapeutics IncCompletedDiffuse Large B-Cell LymphomaUnited States
-
Shanghai Zhongshan HospitalWuxi People's Hospital; Shanghai Minhang Central HospitalCompletedTranslational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell LymphomaLymphoma, Large B-Cell, Diffuse | Gene Expression ProfilingChina